Relationship between daily dose frequency and adherence to antihypertensive pharmacotherapy: Evidence from a meta-analysis

Clinical Therapeutics

Volumn 24, Issue 2, 2002, Pages 302-316

  Iskedjian, Michael ^a   Einarson, Thomas R ^b,c   MacKeigan, Linda D ^b   Shear, Neil ^b,d   Addis, Antonio ^e   Mittmann, Nicole ^d   Ilersich, A Lane ^f  

^a PharmIdeas Research and Consulting Inc   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^e Public Health Department   (Italy)

^f Roche Canada Inc   (Canada)

Author keywords

Adherence; Antihypertensive therapy; Daily dose; Dosing frequency; Hypertension; Multiple daily dosing; Patient compliance

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIURETIC AGENT;

ANTIHYPERTENSIVE THERAPY; ARTICLE; BLOOD PRESSURE; CLINICAL TRIAL; CORRELATION ANALYSIS; DRUG FORMULATION; HUMAN; HYPERTENSION; META ANALYSIS; PATIENT ATTITUDE; PATIENT COMPLIANCE;

EID: 0036193014     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(02)85026-3     Document Type: Article

References (32)

1. Management of patient compliance in the treatment of hypertension. Report of the NHLBI Working Group
2. Estimating the cost of hospital admissions due to patient nonadherence in Ontario, Canada
3. The relative risk of incident coronary heart disease associated with recently stopping the use of beta-blockers
4. Appendix I: Annotated and indexed bibliography on compliance with therapeutic and preventative regimens
5. Patient compliance with antihypertensive medication
6. The effect of medication compliance on the control of hypertension
7. Randomised clinical trial of strategies for improving medication compliance in primary hypertension
8. Adherence to treatment and health outcomes
9. The drug regimen and treatment compliance
10. Determinants of compliance: The disease of the mechanics of treatment
11. Medication compliance in the elderly: A review
12. Medication compliance: A healthcare problem
13. Elders' nonadherence: Its assessment and medication reminding by voice mail
14. The combination of estimates from different experiments
15. Meta-analysis in clinical research
16. Test for outliers
17. A study of efficacy, tolerance and compliance of once-daily versus twice-daily metoprolol (Betaloc) in hypertension
18. Compliance and compliance-improving strategies in hypertension: The Japanese experience
19. The effect of prescribed daily dose frequency on patient medication compliance
20. Patient adherence to prescribed potassium supplement therapy
21. Conversion from sustained-release to immediate-release calcium entry blockers: Outcome in patients with mild-to-moderate hypertension
22. Long-term patient compliance with prescribed regimens of calcium channel blockers
23. Patient compliance and therapeutic coverage: Comparison of amlodipine and slow release nifedipine in the treatment of hypertension
24. Comparison between a bid and a tid regimen: Improved compliance with no improved antihypertensive effect
25. Overview of patient compliance with medication dosing: A literature review
26. A systematic review of the associations between dose regimens and medication compliance
27. Secondary prevention for ischemic heart disease. Relative numbers needed to treat with different therapies
28. Efficacy, dose-response, and safety of ondansetron in prevention of postoperative nausea and vomiting: A quantitative systematic review of randomized placebo-controlled trials
29. Prevention of heart failure by antihypertensive drug treatment in older persons with isolated systolic hypertension
30. Pharmacotherapy for hypertension in women of different races
31. The effects of initial drug choice and comorbidity on antihypertensive therapy compliance. Results from a population-based study in the elderly
32. Hypertension continuation adherence: Natural history and role as an indicator condition